Literature DB >> 6248797

3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.

P J Miach, J P Dausse, A Cardot, P Meyer.   

Abstract

Prazosin is know to block postsynaptic alpha-adrenoceptors. In this study 3H-prazosin has been used to label biochemically central alpha-adrenoceptors. In rat brain membranes 3H-prazosin bound specifically in a rapid, reversible and saturable manner to a single class of high affinity sites. The relative order of potencies for inhibition of 3H-prazosin binding was WB4101 greater than ARC 239 greater than phentolamine greater than piperoxane greater than yohimbine which is a characteristic of the alpha 1 type of adrenoceptors. In contrast, the relative order of potencies for inhibition of 3H-clonidine binding was yohimbine greater than piperoxane greater than WB4101 greater than ARC239 greater than prazosin which is a characteristic of the alpha 2 type of adrenoceptors. These results indicate that 3H-prazosin binds to central 'alpha 1'-receptors and 3H-clonidine to 'alpha 2'-receptors and confirm the presence of two classes of alpha-adrenoceptors in rat brain membranes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248797     DOI: 10.1007/bf00502569

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

Review 2.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Identification and regulation of alpha- and beta-adrenergic receptors.

Authors:  R J Lefkowitz
Journal:  Fed Proc       Date:  1978-02

5.  Prazosin: differential affinities for two populations of alpha-noradrenergic receptor binding sites.

Authors:  D C U'Prichard; M E Charness; D Robertson; S H Snyder
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

6.  Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.

Authors:  D C U'Prichard; W D Bechtel; B M Rouot; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

7.  Biochemical evidence for presynaptic and postsynaptic alpha-adrenoceptors in rat heart membranes: positive homotropic cooperativity of presynaptic binding.

Authors:  P Guicheney; R P Garay; C Levy-Marchal; P Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Specific labelling of postsynaptic alpha 1 adrenoceptors in rat heart ventricle by 3H-WB 4101.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

10.  Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.

Authors:  P Greengrass; R Bremner
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

View more
  20 in total

1.  Evidence for the participation of disulfide and sulfhydril groups in the specific binding of [3H]prazosin in cerebral cortex.

Authors:  T A Reader; R Brière
Journal:  Neurochem Res       Date:  1985-01       Impact factor: 3.996

2.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  D R Thomas; D R Nelson; A M Johnson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  An autoradiographic study of alpha 1-adrenergic receptors in the brain of the Japanese quail (Coturnix coturnix japonica).

Authors:  J Balthazart; G F Ball; B S McEwen
Journal:  Cell Tissue Res       Date:  1989-12       Impact factor: 5.249

5.  Imidazole has similar behavioural effects to yohimbine.

Authors:  F Ferrari; R Martinelli; G Baggio
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.

Authors:  G A McPherson; R J Summers
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

7.  Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain.

Authors:  D B Menkes; J M Baraban; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

8.  The effect of microelectrophoretically applied clonidine on single cerebral cortical neurones in the rat. Evidence for interaction with alpha 1-adrenoceptors.

Authors:  C M Bradshaw; M J Stoker; E Szabadi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

9.  Postjunctional alpha-adrenoceptors. Alpha 1 and alpha 2 subtypes in rat vasculature in vitro and in vivo.

Authors:  N Decker; J D Ehrhardt; G Leclerc; J Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

10.  Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergolene.

Authors:  R Markstein; A Enz; J M Vigouret; A Jaton; A Closse; U Briner; P Gull
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.